You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美单日新增5.39万宗新冠确诊 创近四个月低
阿思达克 02-16 16:06
美国新冠疫情缓和。据美国约翰霍普金斯大学统计,美国截至西岸时间午夜(本港时间下午4时),累计确诊共27,694,165宗,单日新增53,883宗,为去年10月18日以来最少。单日新增死亡个案989宗,为去年11月23日以来最少,累计486,325宗。

各州疫情方面,加州累计349.14万宗确诊,德克萨斯州累计256.8万确诊,佛罗里达州、纽约州及伊利诺伊州各累计183.1万、154.64万及116.36万宗确诊。

据美国疾控中心数据,美国已完成注射近5,288万剂新冠疫苗,累计疫苗分配共7,006万剂。但美国州长协会致函美国总统拜登,指公布数据与州政府实际掌握数字有出入,又指关注联邦政府在州内分发疫苗的行动欠缺透明度,甚至出现州政府与联邦政府重覆分发疫苗的情况。另外,美国航空母舰罗斯福号有3名海军确诊新冠,但没有病徵,紧密接触者已被隔离。

美国过去七日新冠疫情统计:

日期│累计确诊│单日新增确诊│累计死亡│单日新增死亡

2月15日(一)│27,694,165宗│+53,883宗│486,325宗│+989宗

2月14日(日)│27,640,282宗│+64,942宗│485,336宗│+1,088宗

2月13日(六)│27,575,340宗│+83,315宗│484,248宗│+3,361宗

2月12日(五)│27,492,025宗│+101,475宗│480,887宗│+5,596宗

2月11日(四)│27,390,550宗│+103,377宗│475,291宗│+3,724宗

2月10日(三)│27,287,173宗│+94,353宗│471,567宗│+3,364宗

2月9日(二)│27,192,820宗│+95,714宗│468,203宗│+3,131宗

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account